NASDAQ:ASPX

(ASPX) (ASPX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
1.02 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ASPX stock logo

About (ASPX) Stock (NASDAQ:ASPX)

Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254.

ASPX Stock News Headlines

Watch this FREE trading tutorial while it’s still available
On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.
Danville missing man found safe
Watch this FREE trading tutorial while it’s still available
On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.
Cloud DX Reports FY2023 Results
See More Headlines
Receive ASPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ASPX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/16/2015
Today
5/06/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ASPX
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

ASPX Stock Analysis - Frequently Asked Questions

How were (ASPX)'s earnings last quarter?

(ASPX) (NASDAQ:ASPX) announced its earnings results on Monday, March, 16th. The biopharmaceutical company reported ($0.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.59) by $0.15.

What other stocks do shareholders of (ASPX) own?
This page (NASDAQ:ASPX) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners